Next-generation sequencing (NGS) analysis and age-based survival comparison among glioblastoma (GBM) patients: a two-center cohort study
Chul Ou Lee, Sun Yong Park, Yejin Yun, Ju Young Choi, Jae-Sung Park, Sin-Soo Jeun, Yeo Song Kim · 2026
Read Next-generation sequencing (NGS) analysis and age-based survival comparison among glioblastoma (GBM) patients: a two-center cohort study by Chul Ou Lee, Sun Yong Park, Yejin Yun, Ju Young Choi, Jae-Sung Park, Sin-Soo Jeun, Yeo Song Kim (2026) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/PMC13415257.txt.
Description
Chul Ou Lee and co-authors compare glioblastoma genetics and survival by age in a 2026 two-center study. Records covered 124 patients who had surgery between 2017 and 2022, split at age 65. Gene sequencing data came from tumor tissue, and survival was modeled with standard methods.
Older patients lived a median of eleven months, against eighteen months for younger patients. A marker called MGMT methylation, which can aid chemotherapy response, appeared more often in older patients. No gene change differed significantly between age groups after strict testing. Modeling confirmed age, MGMT status, treatment protocol, and extent of tumor removal as independent outcome factors.
Catalog record
| CREATOR | Chul Ou Lee, Sun Yong Park, Yejin Yun, Ju Young Choi, Jae-Sung Park, Sin-Soo Jeun, Yeo Song Kim |
|---|---|
| YEAR | 2026 |
| COLLECTION | PAPERS |
| FORMAT | TXT |
| FILE SIZE | 24142 |
| LICENSE | https://creativecommons.org/licenses/by/4.0 |
| RIGHTS | CC BY |
| SOURCE | Europe PMC |